Taro Pharmaceutical Industries Ltd. Appoints New Chief Financial Officer

HAWTHORNE, N.Y.--(BUSINESS WIRE)--Taro Pharmaceutical Industries Ltd. (“Taro,” the “Company,” Pink Sheets: TAROF) announced today that Ron Kolker, C.P.A., has been appointed to the position of Senior Vice President, Chief Financial Officer of the Company and of the Company’s U.S. subsidiary, Taro Pharmaceuticals U.S.A., Inc. (“Taro USA”).

MORE ON THIS TOPIC